160 related articles for article (PubMed ID: 37747904)
1. CD44-SNA1 integrated cytopathology for delineation of high grade dysplastic and neoplastic oral lesions.
Sunny SP; D R R; Hariharan A; Mukhia N; Gurudath S; G K; Raghavan S; Kolur T; Shetty V; R VB; Surolia A; T S; Chandrashekhar P; R N; Pandya HJ; Pillai V; N PB; Kuriakose MA; Suresh A
PLoS One; 2023; 18(9):e0291972. PubMed ID: 37747904
[TBL] [Abstract][Full Text] [Related]
2. Serum expression of Vascular Endothelial-Cadherin, CD44, Human High mobility group B1, Kallikrein 6 proteins in different stages of laryngeal intraepithelial lesions and early glottis cancer.
Żurek M; Rzepakowska A; Kotuła I; Demkow U; Niemczyk K
PeerJ; 2022; 10():e13104. PubMed ID: 35462765
[TBL] [Abstract][Full Text] [Related]
3. Cancer Stem Cell Markers, CD44 and ALDH1, for Assessment of Cancer Risk in OPMDs and Lymph Node Metastasis in Oral Squamous Cell Carcinoma.
Dhumal SN; Choudhari SK; Patankar S; Ghule SS; Jadhav YB; Masne S
Head Neck Pathol; 2022 Jun; 16(2):453-465. PubMed ID: 34655409
[TBL] [Abstract][Full Text] [Related]
4. Cancer stem cell and its niche in malignant progression of oral potentially malignant disorders.
Surendran S; Siddappa G; Mohan A; Hicks W; Jayaprakash V; Mimikos C; Mahri M; Almarzouki F; Morrell K; Ravi R; Govindan S; Sushma CN; Raghavan N; Birur P; Ilayaraja J; Merzianu M; Reid M; Suresh A; Kuriakose MA
Oral Oncol; 2017 Dec; 75():140-147. PubMed ID: 29224811
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. Putative cancer stem cell marker expression in oral epithelial dysplasia and squamous cell carcinoma.
Abdulmajeed AA; Dalley AJ; Farah CS
J Oral Pathol Med; 2013 Nov; 42(10):755-60. PubMed ID: 23614644
[TBL] [Abstract][Full Text] [Related]
7. Validation of a Point-of-Care Optical Coherence Tomography Device with Machine Learning Algorithm for Detection of Oral Potentially Malignant and Malignant Lesions.
James BL; Sunny SP; Heidari AE; Ramanjinappa RD; Lam T; Tran AV; Kankanala S; Sil S; Tiwari V; Patrick S; Pillai V; Shetty V; Hedne N; Shah D; Shah N; Chen ZP; Kandasarma U; Raghavan SA; Gurudath S; Nagaraj PB; Wilder-Smith P; Suresh A; Kuriakose MA
Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298796
[TBL] [Abstract][Full Text] [Related]
8. A smart tele-cytology point-of-care platform for oral cancer screening.
Sunny S; Baby A; James BL; Balaji D; N V A; Rana MH; Gurpur P; Skandarajah A; D'Ambrosio M; Ramanjinappa RD; Mohan SP; Raghavan N; Kandasarma U; N S; Raghavan S; Hedne N; Koch F; Fletcher DA; Selvam S; Kollegal M; N PB; Ladic L; Suresh A; Pandya HJ; Kuriakose MA
PLoS One; 2019; 14(11):e0224885. PubMed ID: 31730638
[TBL] [Abstract][Full Text] [Related]
9. Increasing diagnostic accuracy to grade dysplasia in Barrett's esophagus using an immunohistochemical panel for CDX2, p120ctn, c-Myc and Jagged1.
Karamchandani DM; Lehman HL; Ohanessian SE; Massé J; Welsh PA; Odze RD; Goldblum JR; Berg AS; Stairs DB
Diagn Pathol; 2016 Feb; 11():23. PubMed ID: 26926447
[TBL] [Abstract][Full Text] [Related]
10. Advances toward fully automated in vivo assessment of oral epithelial dysplasia by nuclear endomicroscopy-A pilot study.
Liese J; Winter K; Glass Ä; Bertolini J; Kämmerer PW; Frerich B; Schiefke I; Remmerbach TW
J Oral Pathol Med; 2017 Nov; 46(10):911-920. PubMed ID: 28677249
[TBL] [Abstract][Full Text] [Related]
11. Image analysis of p53 and cyclin D1 expression in premalignant lesions of the oral mucosa.
Liu SC; Hu Y; Sauter ER; Clapper ML; Chen SY; Lanfranchi HE; Engstrom PF; Klein-Szanto AJ
Anal Quant Cytol Histol; 1999 Apr; 21(2):166-73. PubMed ID: 10560487
[TBL] [Abstract][Full Text] [Related]
12. Point-of-care oral cytology tool for the screening and assessment of potentially malignant oral lesions.
McRae MP; Modak SS; Simmons GW; Trochesset DA; Kerr AR; Thornhill MH; Redding SW; Vigneswaran N; Kang SK; Christodoulides NJ; Murdoch C; Dietl SJ; Markham R; McDevitt JT
Cancer Cytopathol; 2020 Mar; 128(3):207-220. PubMed ID: 32032477
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy of brush biopsy-based cytology for the early detection of oral cancer and precursors in Fanconi anemia.
Velleuer E; Dietrich R; Pomjanski N; de Santana Almeida Araujo IK; Silva de Araujo BE; Sroka I; Biesterfeld S; Böcking A; Schramm M
Cancer Cytopathol; 2020 Jun; 128(6):403-413. PubMed ID: 32022466
[TBL] [Abstract][Full Text] [Related]
14. The combination of autofluorescence endoscopy and molecular biomarkers is a novel diagnostic tool for dysplasia in Barrett's oesophagus.
di Pietro M; Boerwinkel DF; Shariff MK; Liu X; Telakis E; Lao-Sirieix P; Walker E; Couch G; Mills L; Nuckcheddy-Grant T; Slininger S; O'Donovan M; Visser M; Meijer SL; Kaye PV; Wernisch L; Ragunath K; Bergman JJ; Fitzgerald RC
Gut; 2015 Jan; 64(1):49-56. PubMed ID: 24721904
[TBL] [Abstract][Full Text] [Related]
15. Nuclear F-actin Cytology in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
McRae MP; Kerr AR; Janal MN; Thornhill MH; Redding SW; Vigneswaran N; Kang SK; Niederman R; Christodoulides NJ; Trochesset DA; Murdoch C; Dapkins I; Bouquot J; Modak SS; Simmons GW; McDevitt JT
J Dent Res; 2021 May; 100(5):479-486. PubMed ID: 33179547
[TBL] [Abstract][Full Text] [Related]
16. Colposcopy, cervicography, speculoscopy and endoscopy. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial.
van Niekerk WA; Dunton CJ; Richart RM; Hilgarth M; Kato H; Kaufman RH; Mango LJ; Nozawa S; Robinowitz M
Acta Cytol; 1998; 42(1):33-49. PubMed ID: 9479322
[TBL] [Abstract][Full Text] [Related]
17. Glycoprotein CD44 expression in benign, premalignant and malignant epithelial lesions of the larynx: an immunohistochemical study including correlation with Rb, p53, Ki-67 and PCNA.
Ioachim E; Assimakopoulos D; Goussia AC; Peschos D; Skevas A; Agnantis NJ
Histol Histopathol; 1999 Oct; 14(4):1113-8. PubMed ID: 10506927
[TBL] [Abstract][Full Text] [Related]
18. Predicting Progression of Oral Lesions to Malignancy Using Machine Learning.
Wu MP; Hsu G; Varvares MA; Crowson MG
Laryngoscope; 2023 May; 133(5):1156-1162. PubMed ID: 35809030
[TBL] [Abstract][Full Text] [Related]
19. The differential expression of micro-RNAs 21, 200c, 204, 205, and 211 in benign, dysplastic and malignant melanocytic lesions and critical evaluation of their role as diagnostic biomarkers.
Quiohilag K; Caie P; Oniscu A; Brenn T; Harrison D
Virchows Arch; 2020 Jul; 477(1):121-130. PubMed ID: 32388720
[TBL] [Abstract][Full Text] [Related]
20. TOP2A/MCM2, p16
Del Moral-Hernández O; Hernández-Sotelo D; Alarcón-Romero LDC; Mendoza-Catalán MA; Flores-Alfaro E; Castro-Coronel Y; Ortiz-Ortiz J; Leyva-Vázquez MA; Ortuño-Pineda C; Castro-Mora W; Illades-Aguiar B
BMC Cancer; 2021 Jan; 21(1):39. PubMed ID: 33413211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
